Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II trial of MH080 cream in healthy subjects and patients with plaque psoriasis
CTR20230670Phase 2Active
- Sponsor
- Minghui Pharmaceutical, Inc.
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MH080 in plaque psoriasis, sponsored by Minghui Pharmaceutical, Inc.. Started Apr 2023; status: active.
02
Drugs
MH080
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20230670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230670.